Derek J. Sloan

2.8k total citations
89 papers, 1.4k citations indexed

About

Derek J. Sloan is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Derek J. Sloan has authored 89 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 57 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Derek J. Sloan's work include Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (23 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Derek J. Sloan is often cited by papers focused on Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (23 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Derek J. Sloan collaborates with scholars based in United Kingdom, Malawi and United States. Derek J. Sloan's co-authors include Victoria Parris, Geraint Davies, Joseph M. Lewis, Martin Dedicoat, David G. Lalloo, Saye Khoo, Theresa J. Allain, Hannah Ryan, Derek Cocker and Bhagteshwar Singh and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Derek J. Sloan

86 papers receiving 1.4k citations

Peers

Derek J. Sloan
Rada Savic United States
Wing-Wai Yew China
Emanuele Pontali Italy
I. А. Vаsilyevа Russia
Gavin Koh United Kingdom
Huyen Cao United States
James R. Lane United States
Sang Nae Cho South Korea
Peter P. Koopmans Netherlands
Lili Wang China
Rada Savic United States
Derek J. Sloan
Citations per year, relative to Derek J. Sloan Derek J. Sloan (= 1×) peers Rada Savic

Countries citing papers authored by Derek J. Sloan

Since Specialization
Citations

This map shows the geographic impact of Derek J. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Sloan more than expected).

Fields of papers citing papers by Derek J. Sloan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek J. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Sloan. The network helps show where Derek J. Sloan may publish in the future.

Co-authorship network of co-authors of Derek J. Sloan

This figure shows the co-authorship network connecting the top 25 collaborators of Derek J. Sloan. A scholar is included among the top collaborators of Derek J. Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek J. Sloan. Derek J. Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laker, Eva, Melanie R. Nicol, Allan Buzibye, et al.. (2025). A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda. HIV Medicine. 26(4). 592–605. 1 indexed citations
2.
3.
Musisi, Emmanuel, Michael Nevels, Tonney S. Nyirenda, et al.. (2024). Specific human gene expression in response to infection is an effective marker for diagnosis of latent and active tuberculosis. Scientific Reports. 14(1). 26884–26884. 4 indexed citations
4.
5.
Maldonado‐Barragán, Antonio, Stephen E. Mshana, Katherine Keenan, et al.. (2023). Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action. JAC-Antimicrobial Resistance. 6(1). dlae019–dlae019. 7 indexed citations
6.
Sloan, Derek J., et al.. (2023). Estimating Phenotypic Characteristics of Tuberculosis Bacteria. 1110–1113. 1 indexed citations
7.
Arandjelović, Ognjen, et al.. (2023). Localization and phenotyping of tuberculosis bacteria using a combination of deep learning and SVMs. Computers in Biology and Medicine. 167. 107573–107573. 2 indexed citations
8.
Arandjelović, Ognjen, et al.. (2023). Automated Methods for Tuberculosis Detection/Diagnosis: A Literature Review. SHILAP Revista de lepidopterología. 3(3). 724–751. 8 indexed citations
9.
Musaazi, Joseph, Allan Buzibye, Rob E. Aarnoutse, et al.. (2023). Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial Agents and Chemotherapy. 67(11). e0043023–e0043023. 4 indexed citations
10.
Arandjelović, Ognjen, et al.. (2022). Tuberculosis Bacteria Detection and Counting in Fluorescence Microscopy Images Using a Multi-Stage Deep Learning Pipeline. Information. 13(2). 96–96. 17 indexed citations
11.
Sekaggya‐Wiltshire, Christine, Joseph Musaazi, Allan Buzibye, et al.. (2022). Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin. Clinical Infectious Diseases. 76(3). e910–e919. 14 indexed citations
12.
Sloan, Derek J., Wilna Oosthuyzen, Till T. Bachmann, et al.. (2021). MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection. British Journal of Clinical Pharmacology. 87(8). 3206–3217. 13 indexed citations
13.
14.
Chaplin, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2020). STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline. PLoS Medicine. 17(9). e1003344–e1003344. 30 indexed citations
15.
Lawson, Lovett, Konstantina Kontogianni, Thomas Edwards, et al.. (2019). PrimeStore MTM and OMNIgene Sputum for the Preservation of Sputum for Xpert MTB/RIF Testing in Nigeria. Journal of Clinical Medicine. 8(12). 2146–2146. 6 indexed citations
16.
Richardson, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2019). Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ Open. 9(7). e030212–e030212. 3 indexed citations
17.
Millard, James, Henry Pertinez, Laura Bonnett, et al.. (2018). Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation. Journal of Antimicrobial Chemotherapy. 73(7). 1755–1762. 27 indexed citations
18.
Lange, Berit, Ioana D. Olaru, Palwasha Khan, et al.. (2017). Mycobacterium tuberculosistransmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis. European Respiratory Journal. 50(4). 1701044–1701044. 14 indexed citations
19.
Mzinza, David, Derek J. Sloan, Kondwani Jambo, et al.. (2015). Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis. Tuberculosis. 95(4). 463–469. 3 indexed citations
20.
Sloan, Derek J., Sipho Dlamini, & Martin Dedicoat. (2009). Management of cryptoccocal meningitis in resource-limited settings: a systematic review.. PubMed. 99(5). 310–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rada Savic Breakdown of academic impact, for papers by Wing-Wai Yew Breakdown of academic impact, for papers by Emanuele Pontali Breakdown of academic impact, for papers by I. А. Vаsilyevа Breakdown of academic impact, for papers by Gavin Koh Breakdown of academic impact, for papers by Huyen Cao Breakdown of academic impact, for papers by James R. Lane Breakdown of academic impact, for papers by Sang Nae Cho Breakdown of academic impact, for papers by Peter P. Koopmans Breakdown of academic impact, for papers by Lili Wang
Rankless by CCL
2026